Skip to content
OpenCapital
Get started

Bausch + Lomb BLCO Surgical — Selling, general and administrative (Note 4)

Other segment segments

Vision Care
$228M+3.2%
Pharmaceuticals
$138M-9.8%

Similar metrics at other companies

Medtronic logo
MDTMedical Surgical — Selling, general, and administrative expense
$650M+9.6%
Boston Scientific logo
BSXMedSurg — Selling, general and administrative expenses, percentage of net sale
32.8%+1.0pp
Stryker logo
SYKOrthopaedics — Selling, general and administrative expenses
$880M-4.9%
Boston Scientific logo
BSXMedSurg — Selling, general and administrative expenses
$557M+8.8%
Novanta logo
NOVTMedical Solutions — Selling General And Administrative Expense
$16.31M+10.7%
Becton, Dickinson and Company logo
BDXMedical — Segment Selling and Administrative as a Percent of Revenues
2.9%+0.3pp

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%
EPS (diluted)-$0.20+66.7%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.43B+10.2%

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's surgical — selling, general and administrative (note 4).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's surgical — selling, general and administrative (note 4)?
Bausch + Lomb (BLCO) reported surgical — selling, general and administrative (note 4) of $73M in Q1 2026.
How has Bausch + Lomb's surgical — selling, general and administrative (note 4) changed year-over-year?
Bausch + Lomb's surgical — selling, general and administrative (note 4) decreased by 0.0% year-over-year, from $73M to $73M.
What is the long-term trend for Bausch + Lomb's surgical — selling, general and administrative (note 4)?
Over 3 years (2022 to 2025), Bausch + Lomb's surgical — selling, general and administrative (note 4) has grown at a 8.9% compound annual growth rate (CAGR), from $231M to $298M.
What does surgical — selling, general and administrative (note 4) mean?
Includes the operating expenses related to the sales force, marketing, and administrative overhead required to support the surgical business segment. This metric measures the efficiency of the segment's support structure and commercial operations. Monitoring this relative to revenue helps assess the operating leverage of the surgical division.